Skip to main content
. 2014 Aug 25;20(6):905–911. doi: 10.1111/hae.12494

Figure 2.

Figure 2

Residual FVIII activity (FVIII:C) of the FVIII concentrates with three inhibitor dilutions in the haemophilia-mimic case (pdFVIII/VWF: plasma-derived FVIII/VWF complex; pdFVIII: plasma-derived FVIII; rFVIII: full-length recombinant FVIII; BDD-rFVIII: B-domain deleted recombinant FVIII) (n = 3-6). *P < 0.001 with respect to plasma.